Tech Company Financing Transactions
Neuronetics Funding Round
On 9/2/2009, Neuronetics raised $30 million in Series D funding from New Leaf Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
9/2/2009
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
New Leaf Venture Partners (Lead Investor) (Liam Ratcliffe)
Proceeds Purpose
The proceeds of the financing will help further our development of next-generation neuromodulation technologies for the treatment of psychiatric and neurologic disorders.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3222 Phoenixville Pike
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Sullivan
Chief Financial Officer
Peter Donato
Chief Financial Officer
Steve Furlong
VP - Bus. Development
Daniel Guthrie
VP - Bus. Development
Anthony Pui
VP - General Counsel
Andrew Macan
VP - Product Management
Greg Harper
Browse more venture capital transactions:
Prev: 9/1/2009: Skyfire venture capital transaction
Next: 9/2/2009: Ooma venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs